Cherng HJ, Khwaja R, Kanagal-Shamanna R, Tang G, et al. TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysis. Am J Hematol 2022 May 14. doi: 10.1002/ajh.26595.
PMID: 35567779